文献速递淋巴瘤白血病

成人T细胞白血病/淋巴瘤伴HTLV-1感染性HRS样细胞的临床病理特征

Clinicopathological features of adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells.
PubMed 文献 · Blood Adv · 2021-01-01

该研究描述了8例成人T细胞白血病/淋巴瘤(ATLL)伴HTLV-1感染性Hodgkin和Reed-Sternberg(HRS)样细胞的临床病理特征,通过超敏RNA原位杂交检测HTLV-1基本亮氨酸拉链因子(HBZ-ISH)确认感染。所有患者均有淋巴结或纵隔病变,5例处晚期;HRS样细胞表达CD30、CD15、MUM1、CD25及HBZ-ISH,不表达B细胞标志、泛T细胞抗原及EBV。

要点

  • ATLL中HRS样细胞可被HTLV-1感染,与经典CHL的EBV阳性B细胞起源不同。
  • HBZ-ISH是识别HTLV-1感染性HRS样细胞的关键检测手段。
  • HRS样细胞表型为CD30+、CD15+、MUM1+、CD25+、HBZ-ISH+,PAX5-、EBV-。

核心结论

  • ATLL相关HRS样细胞可为HTLV-1感染,且表型与经典霍奇金淋巴瘤不同。

研究设计与样本

  • 回顾性描述8例ATLL伴HTLV-1感染性HRS样细胞的临床病理研究。
  • 采用超敏RNA原位杂交检测HTLV-1 HBZ转录本。

主要发现

  • 8例中4男4女,中位年龄73岁(范围55-81岁)。
  • 所有患者均有淋巴结或纵隔病变,5/8例为晚期疾病。
  • HRS样细胞均表达CD30、CD15、MUM1、CD25和HBZ-ISH,不表达PAX5、泛T细胞抗原及EBV。
  • 5例CD4阳性,6例fascin阳性。
  • 1例侵袭性病程中HBZ见于HRS样细胞及周围淋巴细胞,7例仅见于HRS样细胞且多数对化疗有反应。

关键数值与推荐

  • HRS样细胞HBZ-ISH弥漫阳性且PAX5、EBV阴性,可区别于HTLV-1携带者发生的经典霍奇金淋巴瘤。

临床怎么用

  • 对ATLL中HRS样细胞需检测HBZ-ISH以明确HTLV-1感染状态。
  • HRS样细胞表型(CD30+、CD15+、MUM1+、CD25+、PAX5-、EBV-)有助于鉴别经典霍奇金淋巴瘤。

局限性

  • 缺乏单细胞显微切割PCR分析,无法确定HTLV-1感染性HRS细胞的明确细胞谱系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hodgkin and Reed-Sternberg (HRS) cells, a hallmark of classic Hodgkin lymphoma (CHL), are occasionally detected in non-Hodgkin lymphomas, including adult T-cell leukemia/lymphoma (ATLL), a lymphoid neoplasm caused by human T-cell leukemia virus type 1 (HTLV-1). HRS-like cells associated with ATLL have been described to be of B-cell lineage and infected with Epstein-Barr virus (EBV), not HTLV-1. We herein describe clinicopathological findings in 8 cases (4 males and 4 females; median age, 73 years [range, 55-81 years]) of ATLL with HTLV-1-infected HRS-like cells identified by ultrasensitive RNA in situ hybridization for HTLV-1 basic leucine zipper factor (HBZ-ISH), a specific viral transcript of HTLV-1. All patients showed nodal or mediastinal lesions, and 5 of the 8 patients were at an advanced disease stage. HRS-like cells were positive for CD30, CD15, MUM1, CD25, and HBZ-ISH and negative for B-cell markers, including PAX5, pan-T-cell antigens, and EBV in all cases. Five cases were positive for CD4, and 6 cases were positive for fascin. HBZ was identified in both HRS-like cells and surrounding lymphoid cells in 1 case with an aggressive clinical course and only HRS-like cells in 7 cases, most of whom showed a clinical response regardless of the chemotherapeutic regimen. Even though the definitive lineage typing of the HTLV-1-infected HRS cells is one of the limitations of this study in the absence of single-cell microdissection for polymerase chain reaction analysis, the combination of diffuse HBZ-ISH positivity and negativity for PAX5 and EBV deemed these cases distinct from CHL arising in HTLV-1 carriers.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Karube K, Takatori M, Sakihama S, et al. Clinicopathological features of adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells. Blood Adv. 2021. PMID: 33570645. doi:10.1182/bloodadvances.2020003201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。